Levetiracetam (brand name Keppra) is approved for adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. It is also efficacious in children with partial seizures and there are indications that it may be effective in generalised seizures.
Assessment of patient compliance Assessment of suspected toxicity
SST (gold top), serum (red top) or heparin (green top)
1 mL pre-dose trough sample
Up to 6 weeks
Not currently performed in house; this is a referred test.